Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Professor Alison Simmons, the Director of the Oxford University MRC Human Immunology Unit (MRC HIU), together with Dr Hashem Koohy, group leader at Radcliffe Department of Medicine and the MRC HIU, have been awarded a Chan Zuckerberg Initiative Paediatric Networks for the Human Cell Atlas grant.

Alison Simmons on left  , Hashem Koohy on right

The Chan Zuckerberg Initiative (CZI) has announced $33 million in grants to support collaborative groups of researchers and paediatricians to better understand, prevent, and treat childhood diseases.

These 17 groups of researchers represent 15 different countries, and will contribute healthy paediatric single-cell reference data to the global Human Cell Atlas as a foundational resource for providing insight into the cellular origins of disease onset in children.

Professor Simmons project aims to develop an open access spatiotemporal atlas of childhood intestinal development, with the team building a single-cell atlas of the paediatric intestine. This will help researchers and clinicians understand how the human intestine matures in childhood, as well as adult intestinal diseases.

Professor Simmons team, in collaboration with Dr Koohy’s group, has previously provided open access atlases of the human colon in health and inflammatory bowel disease (IBD), and a resource documenting how the human foetal intestine develops. These resources highlighted an urgent need to undertake studies to better understand how a healthy immune system develops in symbiosis with the intestinal microbiota, and provide a framework to understand both neonatal, childhood, and adult intestinal diseases.

Read the full story on the MRC Weatherall Institute of Molecular Medicine

Similar stories

New research reveals relationship between particular brain circuits and different aspects of mental wellbeing

Researchers at the University of Oxford have uncovered previously unknown details about how changes in the brain contribute to changes in wellbeing.

Night-time blood pressure assessment is found to be important in diagnosing hypertension

Around 15% of people aged 40-75 may have a form of undiagnosed high blood pressure (hypertension) that occurs only at night-time. Because they do not know about this, and therefore are not being treated for it, they are at a higher risk of cardiovascular disease such as stroke, heart failure, and even death, suggests new research from the University of Oxford published in the British Journal of General Practice.

Major new NIHR Global Health Research Unit to focus on data science and genomic surveillance of antimicrobial resistance

The Centre for Genomic Pathogen Surveillance, part of the Big Data Institute at the University of Oxford, has been awarded funding worth £7m for their work as an NIHR Global Health Research Unit (GHRU) for the next five years. The Centre’s research and capacity building work focuses on delivering genomics and enabling data for the surveillance of antimicrobial resistance (AMR).

How artificial intelligence is shaping medical imaging

Dr Qiang Zhang of the Radcliffe Department of Medicine explains how artificial intelligence is being used to help researchers and physicians interpret medical imaging.

Researchers describe how cancer cells can defend themselves from the consequences of certain genetic defects

Researchers in Department of Physiology, Anatomy and Genetics have identified a rescue mechanism that allows cancers to overcome the consequences of inactivating mutations in critically important genes.